SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology

Immune-checkpoint inhibitors (ICIs) transformed treatment paradigms in dozens of malignancies, yet oncologists still confront a deceptively simple question at every consult: Will this individual patient benefit and at what cost?

January 09, 2026

Vol.52 No.1

By Ofer Sharon, Michal Harel and Yehonatan Elon

Clinical Roundup

Proton vs. traditional radiation therapy significantly improves survival in head and neck cancers, MD Anderson-led study finds

Patients with oropharyngeal cancers who were treated with proton therapy, compared to traditional radiation therapy saw a significant survival benefit, according to the findings from a phase III trial led by researchers at the University of Texas MD Anderson Cancer Center.

December 19, 2025

Vol.51 No.46

Regulatory News

ESMO publishes guidances on AI tools for clinicians, patients, and researchers
Says one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.”

The European Society For Medical Oncology has formally weighed in on a question that U.S. medical groups have been chipping away at as well: How can we guarantee safe and effective use of artificial intelligence in oncology?

HHS issues AI strategy for internal agency operations

HHS has issued its AI strategy—“the first step” in making a “whole-of-department transformation” towards the use of artificial intelligence in public health, health care delivery, biomedical research, human services, and agency operations.

AI will determine Medicare prior authorizations in six states under new pilot program

Medicare will soon launch a pilot program that will test the use of AI to automate the prior authorization process—a tool that will recommend whether to approve or deny coverage for a patient in the program.

December 12, 2025

Vol.51 No.45

By Sara Willa Ernst

Fixing site reads without burning out the readers
Yunu modernizes clinical trial imaging assessment workflows

Imaging assessments are a requirement for most oncology trial endpoints. Yet, many cancer centers are still trying to support research trials with clinical care tools and ad hoc processes that are not fit-for-purpose and don’t meet the needs of sponsors or trial staff.

December 05, 2025

Vol.51 No.44

By Jeff Sorenson

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

YOU MAY BE INTERESTED IN

Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology

Proton vs. traditional radiation therapy significantly improves survival in head and neck cancers, MD Anderson-led study finds

ESMO publishes guidances on AI tools for clinicians, patients, and researchers
Says one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.”

HHS issues AI strategy for internal agency operations

AI will determine Medicare prior authorizations in six states under new pilot program

Fixing site reads without burning out the readers
Yunu modernizes clinical trial imaging assessment workflows

Renew today!

Subscriber content

Never miss an issue!

Login

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

YOU MAY BE INTERESTED IN

Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology

Proton vs. traditional radiation therapy significantly improves survival in head and neck cancers, MD Anderson-led study finds

ESMO publishes guidances on AI tools for clinicians, patients, and researchersSays one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.”

HHS issues AI strategy for internal agency operations

AI will determine Medicare prior authorizations in six states under new pilot program

Fixing site reads without burning out the readersYunu modernizes clinical trial imaging assessment workflows

Never miss an issue!

Login

ESMO publishes guidances on AI tools for clinicians, patients, and researchers
Says one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.”

Fixing site reads without burning out the readers
Yunu modernizes clinical trial imaging assessment workflows